Supplemental Table 6 from TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti–PD-1 Immunotherapy
Year: 2025
Type: supplementary-materials
Abstract: 10 patients with STK11-deficient solid tumors enrolled in NCT05887492 provided paired biopsies during Phase 1
Authors: Leanne G. Ahronian, Soumyadip Sahu, Minjie Zhang, Ayushi S. Patel, Ke Geng, Reshmee Bhattacharya, Gerald S. Falchook, Jonathan W. Goldman, Alexander I. Spira, Salman R. Punekar, David R. Spigel, Judy S. Wang, Ferdinandos Skoulidis, Janaye Stephens, Mary Meynardie, Jaylen M. Powell, Alfonso Lopez, Michela Ranieri, Magdalena A. Ploszaj, Yi Jer Tan, Yeuan Ting Lee, Yi Yu, Jiehui Deng, Ting Chen, Patrick McCarren, Alice Tsai, Suleman S. Hussain, Brian Doyon, Kenjie Amemiya, Jacques Ermolieff, Preksha Shahagadkar, Nikitha M. Das, Lauren R. Flynn, Julie A. Shields, Laney Danielczyk, Brian J. McMillan, Andre Mignault, Samuel R. Meier, Hsin-Jung Wu, David J. Guerin, Douglas A. Whittington, Chengyin Min, Iga Sienczylo, John P. Maxwell, Heather J. DiBenedetto, Hideo Watanabe, Brian B. Haines, Alan Huang, Adam Crystal, Jannik N. Andersen, Xinyuan Wu, Kwok-Kin Wong
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4415210600
Cites:
Cited by:
Related to: